These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 30803452)
1. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary. Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452 [TBL] [Abstract][Full Text] [Related]
2. Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer. Li M; Tan J; Zhang Y; Ai C; Wang H; Zhang H; Jin Y; Chen Y Abdom Radiol (NY); 2021 Jun; 46(6):2367-2375. PubMed ID: 32424610 [TBL] [Abstract][Full Text] [Related]
3. Preoperative discrimination of tumour stage in clear cell carcinoma of the ovary using computed tomography and magnetic resonance imaging. Joo HL; Shin YR; Rha SE; Park CS; Shim DJ; Kim K Eur J Radiol; 2018 Dec; 109():19-26. PubMed ID: 30527303 [TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation. Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924 [TBL] [Abstract][Full Text] [Related]
5. Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules. Tanase Y; Kawaguchi R; Takahama J; Kobayashi H Magn Reson Med Sci; 2018 Jul; 17(3):231-237. PubMed ID: 28824051 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study. Takeyama N; Sasaki Y; Ueda Y; Tashiro Y; Tanaka E; Nagai K; Morioka M; Ogawa T; Tate G; Hashimoto T; Ohgiya Y Jpn J Radiol; 2024 Jul; 42(7):731-743. PubMed ID: 38472624 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307 [TBL] [Abstract][Full Text] [Related]
8. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma. Ju UC; Kang WD; Kim SM Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117 [TBL] [Abstract][Full Text] [Related]
9. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging. Zhang X; Li M; Tang Z; Li X; Song T Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252 [TBL] [Abstract][Full Text] [Related]
10. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study. Zhou L; Yao L; Dai L; Zhu H; Ye X; Wang S; Cheng H; Ma R; Liu H; Cui H; Chang X J Ovarian Res; 2021 May; 14(1):63. PubMed ID: 33941230 [TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma. Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079 [TBL] [Abstract][Full Text] [Related]
12. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas? McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L Eur J Surg Oncol; 2024 Jun; 50(6):108247. PubMed ID: 38522332 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma. Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917 [TBL] [Abstract][Full Text] [Related]
14. Clear cell carcinoma of the ovary: comparison of MR findings of histological subtypes. Kato H; Hatano Y; Makino H; Furui T; Morishige KI; Matsuo M Abdom Radiol (NY); 2016 Dec; 41(12):2476-2483. PubMed ID: 27167231 [TBL] [Abstract][Full Text] [Related]
15. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma. Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131 [TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832 [TBL] [Abstract][Full Text] [Related]
18. The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma. Qu J; Yu J; Zhong S; Wang W; Wang Q; Du B Virchows Arch; 2023 Jun; 482(6):1021-1034. PubMed ID: 36580137 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis. Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound, macroscopic and histological features of endometrioid and clear cell ovarian cancer. Bolomini G; Bertoldo V; Zannoni GF; Pozzati F Int J Gynecol Cancer; 2021 Jun; 31(6):938-939. PubMed ID: 33139316 [No Abstract] [Full Text] [Related] [Next] [New Search]